Pharmacologic stress echocardiography predicts total mortality early after acute myocardial infarction

Area of Science:

• Cardiology
• Diagnostic Imaging
• Clinical Research

Background:

• Assessing risk in survivors of a first acute myocardial infarction (MI) is crucial for guiding post-discharge management.
• Inducible ischemia detected by stress testing is a key indicator of cardiac risk.

Purpose of the Study:

• To evaluate the prognostic value of pharmacologic stress echocardiography (DET) in a large cohort of patients after an uncomplicated first MI.
• To determine if inducible ischemia detected by DET can effectively stratify risk in this population.

Main Methods:

• A multicenter, prospective, observational study involving 1681 survivors of a first acute uncomplicated MI.
• Pharmacologic stress echocardiography (DET) using high-dose dipyridamole or dobutamine was performed early post-MI.
• Patients were followed for a mean of 16 months to track hard events, including all-cause mortality, cardiac death, nonfatal MI, and hospital readmissions.

Main Results:

• DET was positive for inducible ischemia in 52.5% of patients and negative in 47.5%.
• Patients with positive DET had a significantly higher rate of hard events (8%) compared to those with negative DET (5%) (P =.014).
• Independent predictors of all-cause death included age, history of angina, peak wall-motion score index, and pharmacologic dose at ischemia.

Conclusions:

• Pharmacologic stress echocardiography (DET) is a valuable tool for risk stratification in survivors of a first acute uncomplicated MI.
• The presence, severity, and extent of induced ischemia identified by DET correlate with future adverse cardiac events.
• DET findings can inform clinical decisions and guide further management strategies for post-MI patients.